Cargando…

HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma

While chimeric antigen receptor (CAR)-T-cell therapy has demonstrated remarkable effectiveness in the treatment of B-cell lymphomas and leukemias, research on T-cell malignancies is still limited. Here, we reported a patient with hepatosplenic γδ T-cell lymphoma refractory to multiple lines of chemo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xueer, Zu, Cheng, Zhang, Mingming, Xiao, Pingnan, Hong, Ruimin, Feng, Jingjing, Xu, Huijun, Cui, Jiazhen, Yu, Jian, Shi, Jimin, Wei, Guoqing, Chang, Alex H., Huang, He, Hu, Yongxian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Case Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481705/ https://www.ncbi.nlm.nih.gov/pubmed/37667507 http://dx.doi.org/10.1177/09636897231194265

Ejemplares similares

A case of hepatosplenic T-cell lymphoma successfully treated by HLA haploidentical stem cell transplantation
por: Iwaki, Noriko, et al.
Publicado: (2020)

Risk Factors Associated with Durable Progression-Free Survival in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti-BCMA CAR T-cell Therapy
por: Zhang, Mingming, et al.
Publicado: (2021)

Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells
por: Wilhelm, Martin, et al.
Publicado: (2014)

Aberrant Loss of Surface CD3 and TCRγδ Expression in Relapsed Hepatosplenic T-cell Lymphoma
por: Lee, Beomki, et al.
Publicado: (2021)

Profuse telangiectasias in an immunocompetent patient misleading presentation revealing a hepatosplenic‐Tγδ‐cell lymphoma
por: Diarra, Ava, et al.
Publicado: (2022)

Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha/beta (αβ) T-cell lymphoma
por: Catania, Gioacchino, et al.
Publicado: (2014)

Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I study
por: Hu, Yongxian, et al.
Publicado: (2023)

Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report
por: Jin, Mengqi, et al.
Publicado: (2019)

Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report
por: Jin, Mengqi, et al.
Publicado: (2019)

Single cell profiling of γδ hepatosplenic T-cell lymphoma unravels tumor cell heterogeneity associated with disease progression
por: Song, Wei, et al.
Publicado: (2022)

Haploidentical transplants deliver equal outcomes to matched sibling transplants: a propensity score-matched analysis
por: Wu, Hengwei, et al.
Publicado: (2023)

Safety and efficacy of autologous and allogeneic humanized CD19-targeted CAR-T cell therapy for patients with relapsed/refractory B-ALL
por: Song, Fengmei, et al.
Publicado: (2023)

Use of PEG-asparaginase in a case of Hepatosplenic γδ T-cell lymphoma with long-term remission after stem cell transplantation
por: Sun, Kai, et al.
Publicado: (2018)

Macronodular hepatosplenic tuberculosis
por: Guidi, Roberto, et al.
Publicado: (2012)

Myeloablative Haploidentical Transplant as an Alternative to Matched Sibling Transplant for Peripheral T-Cell Lymphomas
por: Zhenyang, Gu, et al.
Publicado: (2021)

Haploidentical γδ T Cells Induce Complete Remission in Chemorefractory B-cell Non-Hodgkin Lymphoma
por: Bold, Anna, et al.
Publicado: (2023)

Haploidentical vs matched sibling donor transplant for paroxysmal nocturnal haemoglobinuria: A multicenter study
por: Liu, Limin, et al.
Publicado: (2022)

A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
por: Wang, Yiyun, et al.
Publicado: (2020)

Successful BCMA CAR-T Therapy for Multiple Myeloma With Central Nervous System Involvement Manifesting as Cauda Equina Syndrome—A Wandering Road to Remission
por: Wang, Yiyun, et al.
Publicado: (2021)

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia
por: Wieduwilt, Matthew J., et al.
Publicado: (2022)

Comparison of efficacies of haploidentical transplantation and matched sibling donor transplantation in treating T‐cell lymphoblastic lymphoma
por: Wei, Ruowen, et al.
Publicado: (2023)

Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study
por: Zhao, Houli, et al.
Publicado: (2020)

Pomalidomide-based regimens bridging CAR-T therapy in multiple myeloma with central nervous system involvement
por: Zhang, Qiqi, et al.
Publicado: (2022)

Simultaneous hepatosplenic T-cell lymphoma and myelofibrosis
por: Gabali, Ali M, et al.
Publicado: (2014)

Hepatosplenic Sarcoidosis Complicated by Liver Cirrhosis
por: Peters, B., et al.
Publicado: (2015)

Hepatosplenic T Cell Lymphoma: Diagnostic Conundrum
por: Chowdhury, Zachariah, et al.
Publicado: (2022)

Autoimmune hematological diseases following haploidentical donor hematopoietic stem cell transplant compared with matched sibling and unrelated donor
por: Lv, Weiran, et al.
Publicado: (2017)

Haploidentical‐ versus identical‐sibling transplant for high‐risk pediatric AML: A multi‐center study
por: Zheng, Feng-Mei, et al.
Publicado: (2020)

Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti‐Leukemia Efficacy of CAR‐T Cells via SOCE‐Calcineurin‐NFAT and Glycolysis Pathways
por: Shao, Mi, et al.
Publicado: (2022)

A multivariate CAR model for mismatched lattices()
por: Porter, Aaron T., et al.
Publicado: (2014)

A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia
por: Vydra, Jan, et al.
Publicado: (2023)

Editorial: Hepatosplenic schistosomiasis: a tropical noncirrhosis.
por: Conn, H. O.
Publicado: (1975)

Hepatosplenic T-cell lymphoma with hepatocytotropism in a cat
por: Ii, Tatsuhito, et al.
Publicado: (2021)

Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation
por: Zhang, Xiaoyu, et al.
Publicado: (2022)

New case of HIV cure: joined forces of haploidentical stem cells and HLA-mismatched cord blood
por: Peterhoff, David
Publicado: (2023)

Preventive infusion of donor-derived CAR-T cells after haploidentical transplantation: Two cases report
por: Zhang, Cheng, et al.
Publicado: (2019)

Haploidentical donor-derived memory CAR T cells: first in human experience and in vitro correlative study
por: Ukrainskaya, Valeria, et al.
Publicado: (2022)

A good response of refractory mantel cell lymphoma to haploidentical CAR T cell therapy after failure of autologous CAR T cell therapy
por: Li, Tongjuan, et al.
Publicado: (2019)

Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse
por: Ding, Lijuan, et al.
Publicado: (2021)

Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study
por: Xu, Zheng-Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6bh1152to8jtf11ssr2dh9659j